102710 - ENF Technology Co., Ltd.

102710 Summary
Chemicals
Stock Price & Overview
₩41,950 +900 (+2.19%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩41,950  ≈ US$30  ·  Market cap ₩0.6tn (≈ $428m)

102710 Financial Statements

Breakdown ₩ bnFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total Revenue670.9582.4531.1680.2521.8486.6481.0425.4387.0334.3311.9
Cost of Revenue512.7450.2442.0544.8436.4368.9373.8349.6304.3254.1235.5
Gross Profit158.2132.289.1135.485.4117.7107.275.882.780.276.3
Selling, General & Administrative80.172.965.270.859.449.547.640.237.338.838.5
Operating Income78.159.323.964.626.068.259.635.645.341.337.9
Finance Income6.610.18.117.76.96.87.44.23.1-1.3-0.8
Finance Costs15.314.315.217.84.99.27.54.56.8-7.3-5.2
Pretax Income70.253.1-19.863.829.263.459.238.244.233.338.2
Income Tax Expense19.920.73.318.811.215.912.49.29.911.79.2
Net Income50.329.7-23.245.018.047.446.729.026.021.629.0
Total Comprehensive Income50.837.2-23.346.725.846.446.227.624.9
Consolidated (CFS), from DART. 11 fiscal years and 10 quarters. Accounts matched on IFRS account_id, not Korean labels, so the same line holds across years where the Korean wording changed. Quarterly figures are three-month values: income quarters from DART's three-month column, cash-flow quarters differenced from DART's cumulative figures, and Q4 as annual minus nine-month cumulative.

102710 Growth

FY2025 ₩bnLatest1-yr3-yr CAGR5-yr CAGR10-yr CAGR
Revenue670.9+15.2%-0.5%+6.6%+8.0%
Operating income78.1+31.6%+6.5%+2.8%+7.5%
Net income50.3+69.2%+3.8%+1.2%+5.6%
EPS₩3,521+69.2%+3.8%+1.2%+5.6%
Operating cash flow103.1-4.4%+19.2%+6.8%+10.3%
Shareholders' equity450.1+12.1%+4.7%+7.4%+11.9%
Compound annual growth from the DART annual statements on this page. n/m where either end of the period is a loss or missing. EPS uses today's share count for every year.

102710 Profitability

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin23.6%22.7%16.8%19.9%16.4%24.2%
Operating margin11.6%10.2%4.5%9.5%5.0%14.0%
Net margin7.5%5.1%-4.4%6.6%3.5%9.7%
Return on equity11.8%7.7%-6.1%12.2%5.5%16.3%
Return on assets6.8%4.3%-3.5%7.2%3.4%11.2%
Operating cash flow / revenue15.4%18.5%9.7%8.9%2.8%15.2%
Capex / revenue7.7%12.5%17.6%
Margins divide by revenue for the same year. Return on equity and assets divide net income by the average of that year's and the prior year's balance, as DART reports them (consolidated, including minority interests).

Similar to 102710

SymbolLast Price
268280Miwon Specialty Chemical₩130,700
-1.3%
001570Kumyang Co., Ltd.₩9,900
+0.0%
014820Dongwon Systems Corporation₩21,700
-2.3%
006650Korea Petro Chemical IND₩96,700
+0.3%
006380Capro Corporation₩3,660
+0.0%
048410Hyundai Bioscience Co., Ltd.₩6,210
+2.6%
002350Nexen Tire Corporation₩6,080
+0.0%
002840Miwon Commercial Co., Ltd.₩130,000
-1.1%
121600Advanced Nano Products Co., Ltd.₩47,000
+0.1%
178920PI Advanced Materials Co., Ltd.₩19,030
+0.8%
Compare all 43 in Chemicals

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.